EXAS logo

Exact Sciences (EXAS) EBITDA

Annual EBITDA

-$789.33 M
-$818.61 M-2795.52%

December 31, 2024

Summary

Performance

1-Year Change

-2795.52%

3-Year Change

-21.57%

5-Year Change

-127.17%

15-Year Change

-698.73%

EXAS EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

0.8%
EXAS annual EBITDA is higher than 0.8% of companies in Healthcare sector

High & Low

All-time High

$29.28 M
EXAS annual EBITDA is currently -2795.52% below its historical high of $29.28 million

3-Year Low

-$789.33 M
EXAS annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
EXAS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
EXAS next annual earnings announcement has not yet been scheduled

OtherEXASprofitabilitymetrics:

Annual Revenue

$2.76 B
EXAS annual revenue is $2.76 billion

Annual Net Income

-$1.03 B
EXAS annual net profit is -$1.03 billion

Annual EBIT

-$1.00 B
EXAS annual earnings before interest & taxes is -$1.00 billion

Annual EPS

-$5.59
EXAS annual earnings per share is -$5.59

Quarterly EBITDA

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

EXAS Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$59.84 M
EXAS quarterly EBITDA is currently at an all-time high

3-Year Low

-$176.51 M
EXAS quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
EXAS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
EXAS next earnings announcement has not yet been scheduled

OtherEXASprofitabilitymetrics:

Quarterly Revenue

$713.42 M
EXAS quarterly revenue is $713.42 million

Quarterly Net Income

-$864.59 M
EXAS quarterly net profit is -$864.59 million

Quarterly EBIT

-
EXAS quarterly earnings before interest & taxes value is unknown

Quarterly EPS

-$4.67
EXAS quarterly earnings per share is -$4.67

TTM EBITDA

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

EXAS TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$58.50 M
EXAS TTM EBITDA is currently at an all-time high

3-Year Low

-$649.28 M
EXAS TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
EXAS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
EXAS next earnings announcement has not yet been scheduled

OtherEXASprofitabilitymetrics:

TTM Revenue

$2.76 B
EXAS TTM revenue is $2.76 billion

TTM Net Income

-$1.03 B
EXAS TTM net profit is -$1.03 billion

TTM EBIT

-
EXAS TTM earnings before interest & taxes value is unknown

TTM EPS

-$5.57
EXAS TTM earnings per share is -$5.57

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$789.33 M
EXAS annual EBITDA is -$789.33 million

Annual Net Income

-$1.03 B
EXAS annual net profit is -$1.03 billion

Annual Interest Expense

$31.97 M
EXAS annual interest expense is $31.97 million

Annual Income Tax

-$7.30 M
EXAS annual income tax is -$7.30 million

Annual D&A

$214.86 M
EXAS annual depreciation & amortization is $214.86 million

EXAS EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-2795.5%--
3 y3 years-21.6%--
5 y5 years-127.2%--

EXAS EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2795.5%at low
5 y5-year-2795.5%at low
alltimeall time-2795.5%at low

Exact Sciences EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$789.33 M(-2795.5%)
-
-
Sep 2024
-
$25.62 M(-26.5%)
$24.28 M(-58.5%)
Jun 2024
-
$34.87 M(-174.9%)
$58.50 M(-2582.1%)
Mar 2024
-
-$46.54 M(-550.4%)
-$2.36 M(-114.0%)
Dec 2023
$29.28 M(-107.0%)
$10.33 M(-82.7%)
$16.82 M(-124.0%)
Sep 2023
-
$59.84 M(-330.2%)
-$69.99 M(-69.5%)
Jun 2023
-
-$25.99 M(-5.0%)
-$229.34 M(-27.1%)
Mar 2023
-
-$27.35 M(-64.2%)
-$314.79 M(-25.1%)
Dec 2022
-$421.11 M(-35.1%)
-$76.48 M(-23.1%)
-$420.14 M(-19.2%)
Sep 2022
-
-$99.52 M(-10.7%)
-$520.17 M(-4.0%)
Jun 2022
-
-$111.44 M(-16.0%)
-$542.02 M(-2.3%)
Mar 2022
-
-$132.70 M(-24.8%)
-$554.92 M(-14.5%)
Dec 2021
-$649.28 M(-0.7%)
-$176.51 M(+45.4%)
-$649.28 M(-23.5%)
Sep 2021
-
-$121.36 M(-2.4%)
-$848.33 M(-4.3%)
Jun 2021
-
-$124.34 M(-45.2%)
-$886.08 M(+12.7%)
Mar 2021
-
-$227.07 M(-39.5%)
-$786.21 M(+20.4%)
Dec 2020
-$653.88 M(+88.2%)
-$375.56 M(+136.0%)
-$652.89 M(+25.0%)
Sep 2020
-
-$159.11 M(+550.3%)
-$522.14 M(+37.0%)
Jun 2020
-
-$24.47 M(-73.9%)
-$381.16 M(+1.5%)
Mar 2020
-
-$93.75 M(-61.7%)
-$375.69 M(+8.1%)
Dec 2019
-$347.46 M(+195.8%)
-$244.81 M(+1250.3%)
-$347.46 M(+146.4%)
Sep 2019
-
-$18.13 M(-4.6%)
-$141.03 M(-6.8%)
Jun 2019
-
-$19.00 M(-71.0%)
-$151.38 M(-2.4%)
Mar 2019
-
-$65.53 M(+70.7%)
-$155.02 M(+32.0%)
Dec 2018
-$117.46 M(+18.9%)
-$38.38 M(+34.8%)
-$117.46 M(+21.9%)
Sep 2018
-
-$28.47 M(+25.8%)
-$96.34 M(+6.1%)
Jun 2018
-
-$22.64 M(-19.0%)
-$90.84 M(-4.6%)
Mar 2018
-
-$27.96 M(+61.9%)
-$95.19 M(-3.7%)
Dec 2017
-$98.82 M(-36.4%)
-$17.27 M(-24.8%)
-$98.82 M(-14.5%)
Sep 2017
-
-$22.97 M(-14.9%)
-$115.55 M(-9.3%)
Jun 2017
-
-$26.99 M(-14.6%)
-$127.33 M(-10.5%)
Mar 2017
-
-$31.60 M(-7.1%)
-$142.21 M(-8.6%)
Dec 2016
-$155.49 M(+3.6%)
-$34.00 M(-2.2%)
-$155.53 M(-1.8%)
Sep 2016
-
-$34.75 M(-17.0%)
-$158.36 M(-3.9%)
Jun 2016
-
-$41.87 M(-6.8%)
-$164.78 M(+2.7%)
Mar 2016
-
-$44.91 M(+21.9%)
-$160.52 M(+7.1%)
Dec 2015
-$150.05 M(+55.9%)
-$36.83 M(-10.6%)
-$149.82 M(+4.4%)
Sep 2015
-
-$41.17 M(+9.5%)
-$143.56 M(+7.4%)
Jun 2015
-
-$37.60 M(+9.9%)
-$133.66 M(+16.3%)
Mar 2015
-
-$34.22 M(+11.9%)
-$114.91 M(+19.5%)
Dec 2014
-$96.23 M(+113.9%)
-$30.57 M(-2.2%)
-$96.14 M(+24.5%)
Sep 2014
-
-$31.27 M(+65.9%)
-$77.21 M(+36.0%)
Jun 2014
-
-$18.85 M(+22.0%)
-$56.77 M(+13.9%)
Mar 2014
-
-$15.45 M(+32.7%)
-$49.85 M(+11.1%)
Dec 2013
-$44.98 M(-12.5%)
-$11.64 M(+7.5%)
-$44.88 M(-4.3%)
Sep 2013
-
-$10.83 M(-9.3%)
-$46.87 M(-3.7%)
Jun 2013
-
-$11.94 M(+14.0%)
-$48.69 M(-5.2%)
Mar 2013
-
-$10.47 M(-23.2%)
-$51.38 M(+0.2%)
Dec 2012
-$51.40 M
-$13.63 M(+7.8%)
-$51.30 M(+8.6%)
DateAnnualQuarterlyTTM
Sep 2012
-
-$12.64 M(-13.5%)
-$47.24 M(+11.6%)
Jun 2012
-
-$14.62 M(+40.7%)
-$42.32 M(+23.5%)
Mar 2012
-
-$10.39 M(+8.5%)
-$34.26 M(+21.5%)
Dec 2011
-$28.21 M(+150.1%)
-$9.58 M(+24.0%)
-$28.21 M(+27.8%)
Sep 2011
-
-$7.73 M(+17.7%)
-$22.07 M(+24.9%)
Jun 2011
-
-$6.56 M(+51.4%)
-$17.67 M(+30.6%)
Mar 2011
-
-$4.33 M(+26.0%)
-$13.54 M(+20.0%)
Dec 2010
-$11.28 M(+24.3%)
-$3.44 M(+3.2%)
-$11.28 M(+16.8%)
Sep 2010
-
-$3.33 M(+37.4%)
-$9.65 M(+30.8%)
Jun 2010
-
-$2.43 M(+17.0%)
-$7.38 M(-0.0%)
Mar 2010
-
-$2.08 M(+14.1%)
-$7.38 M(-18.7%)
Dec 2009
-$9.07 M(+3.8%)
-$1.82 M(+71.9%)
-$9.07 M(-1.0%)
Sep 2009
-
-$1.06 M(-56.4%)
-$9.17 M(-7.2%)
Jun 2009
-
-$2.43 M(-35.6%)
-$9.88 M(+4.3%)
Mar 2009
-
-$3.77 M(+96.8%)
-$9.48 M(+13.5%)
Dec 2008
-$8.74 M(-25.1%)
-$1.92 M(+8.1%)
-$8.35 M(-18.7%)
Sep 2008
-
-$1.77 M(-12.4%)
-$10.28 M(+5.3%)
Jun 2008
-
-$2.02 M(-23.5%)
-$9.77 M(-0.4%)
Mar 2008
-
-$2.64 M(-31.2%)
-$9.81 M(+5.3%)
Dec 2007
-$11.67 M(-13.5%)
-$3.84 M(+205.2%)
-$9.31 M(+23.8%)
Sep 2007
-
-$1.26 M(-39.0%)
-$7.52 M(-22.2%)
Jun 2007
-
-$2.06 M(-3.8%)
-$9.67 M(-13.4%)
Mar 2007
-
-$2.15 M(+4.5%)
-$11.16 M(-17.3%)
Dec 2006
-$13.50 M(-10.1%)
-$2.05 M(-39.7%)
-$13.50 M(-6.6%)
Sep 2006
-
-$3.40 M(-4.4%)
-$14.46 M(-1.2%)
Jun 2006
-
-$3.56 M(-20.6%)
-$14.63 M(-4.3%)
Mar 2006
-
-$4.48 M(+48.8%)
-$15.28 M(+1.8%)
Dec 2005
-$15.01 M(-21.8%)
-$3.01 M(-15.8%)
-$15.01 M(-10.4%)
Sep 2005
-
-$3.58 M(-15.0%)
-$16.75 M(-5.6%)
Jun 2005
-
-$4.21 M(+0.2%)
-$17.75 M(-1.3%)
Mar 2005
-
-$4.21 M(-11.6%)
-$17.99 M(-6.3%)
Dec 2004
-$19.20 M(-33.4%)
-$4.75 M(+3.8%)
-$19.20 M(-5.2%)
Sep 2004
-
-$4.58 M(+2.9%)
-$20.25 M(-10.5%)
Jun 2004
-
-$4.45 M(-17.7%)
-$22.64 M(-12.4%)
Mar 2004
-
-$5.41 M(-6.9%)
-$25.84 M(-8.7%)
Dec 2003
-$28.84 M(+0.5%)
-$5.81 M(-16.5%)
-$28.30 M(-0.9%)
Sep 2003
-
-$6.96 M(-9.0%)
-$28.56 M(-1.8%)
Jun 2003
-
-$7.66 M(-2.7%)
-$29.08 M(-0.2%)
Mar 2003
-
-$7.87 M(+29.6%)
-$29.15 M(+1.6%)
Dec 2002
-$28.69 M(+14.1%)
-$6.07 M(-18.8%)
-$28.69 M(-2.5%)
Sep 2002
-
-$7.48 M(-3.2%)
-$29.43 M(+5.2%)
Jun 2002
-
-$7.72 M(+4.2%)
-$27.98 M(+5.4%)
Mar 2002
-
-$7.41 M(+8.7%)
-$26.55 M(+5.7%)
Dec 2001
-$25.13 M(+158.0%)
-$6.82 M(+13.1%)
-$25.13 M(+37.2%)
Sep 2001
-
-$6.03 M(-4.3%)
-$18.32 M(+49.0%)
Jun 2001
-
-$6.30 M(+5.2%)
-$12.29 M(+105.2%)
Mar 2001
-
-$5.99 M
-$5.99 M
Dec 2000
-$9.74 M(+101.3%)
-
-
Dec 1999
-$4.84 M(+20.3%)
-
-
Dec 1998
-$4.02 M
-
-

FAQ

  • What is Exact Sciences annual EBITDA?
  • What is the all time high annual EBITDA for Exact Sciences?
  • What is Exact Sciences annual EBITDA year-on-year change?
  • What is the all time high quarterly EBITDA for Exact Sciences?
  • What is the all time high TTM EBITDA for Exact Sciences?

What is Exact Sciences annual EBITDA?

The current annual EBITDA of EXAS is -$789.33 M

What is the all time high annual EBITDA for Exact Sciences?

Exact Sciences all-time high annual EBITDA is $29.28 M

What is Exact Sciences annual EBITDA year-on-year change?

Over the past year, EXAS annual EBITDA has changed by -$818.61 M (-2795.52%)

What is the all time high quarterly EBITDA for Exact Sciences?

Exact Sciences all-time high quarterly EBITDA is $59.84 M

What is the all time high TTM EBITDA for Exact Sciences?

Exact Sciences all-time high TTM EBITDA is $58.50 M